Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Goodwill & Intangibles: 2017-2024

Historic Goodwill & Intangibles for Adma Biologics (ADMA) over the last 7 years, with Dec 2024 value amounting to $4.0 million.

  • Adma Biologics' Goodwill & Intangibles fell 55.79% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 55.79%. This contributed to the annual value of $4.0 million for FY2024, which is 54.38% down from last year.
  • As of FY2024, Adma Biologics' Goodwill & Intangibles stood at $4.0 million, which was down 54.38% from $8.7 million recorded in FY2023.
  • Over the past 5 years, Adma Biologics' Goodwill & Intangibles peaked at $8.7 million during FY2023, and registered a low of $4.0 million during FY2024.
  • Over the past 3 years, Adma Biologics' median Goodwill & Intangibles value was $8.5 million (recorded in 2022), while the average stood at $7.1 million.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first grew by 2.46% in 2023, then plummeted by 54.38% in 2024.
  • Over the past 5 years, Adma Biologics' Goodwill & Intangibles (Yearly) stood at $8.5 million in 2020, then remained steady at $8.5 million in 2021, then rose by 0.00% to $8.5 million in 2022, then rose by 2.46% to $8.7 million in 2023, then tumbled by 54.38% to $4.0 million in 2024.